title: [Immunological reactivity of the body in cancer of the corpus uteri].
abstract: Under study were the factors of antitumor immunity (RHDT, the reaction of microprecipitation, the functional activity of lymphocytes, RFC and RBT) in 104 patients with cancer of the corpus uteri. It was found that most patients show an impaired immunobiological response, manifested in higher percentage of positive results with RHDT performed with the tumor antigen, and the reaction of microprecipitation with tumor and embryonal antigens, more week RFC and RBT. Immunological indices are getting worse with the process spread and are improved following the combination therapy. The process of treatment however (surgery and radiotherapy) renders a negative effect on immune indices. Normalization of the latter is noted not earlier than 1-3 years after the treatment.
mesh_terms: D000368:Aged; D000937:Antigen-Antibody Reactions; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007109:Immunity; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008875:Middle Aged; D012397:Rosette Formation; D014594:Uterine Neoplasms / Q000276:immunology*
vernacular_title: K voprosu ob immunologicheskoĭ reaktivnosti organizma bol'nykh rakom tela matki.